Pharma Export Grows Over 9% In September

New Delhi: Exports of pharmaceutical products from the country have reported a 9.01 per cent growth during the month of September as compared to the same period of previous year. For the first six months of the current fiscal year, the exports have posted a 5.02 per cent growth.

According to data from the Central Government, the exports during the month of September, 2023 stood at $2.39 billion as compared to $2.19 billion during the same month of last year.

The growth compared to the exports of $2.24 billion in the previous month of August is around 6.7 per cent.

For the six months from April to September, 2023, the exports were at $13.36 billion as compared to $12.72 billion reported during the same period of previous year.

Imports have reported a 3.38 per cent growth during the month of September, at $623.48 million as compared to $603.11 million registered during the same month of last year. The cumulative imports from April to September, 2023 grew marginally to $4.07 billion as compared to $4.06 billion during the same period of previous fiscal year.

The Ministry of Health and Family Welfare in June, this year, said that India’s drug and pharmaceutical products exports grew by 125 per cent from Rs. 90,415 Crore in 2013-14 to Rs. 2,04,110 Crore in 2022-23.

Drugs and Pharmaceuticals exports constitute 5.71 per cent of the total exports from India. India ranks 3rd worldwide for the production of Drugs and Pharmaceuticals by volume exporting to around 200 countries/territories with the top 5 destinations being the USA, Belgium, South Africa, UK, and Brazil.

India accounts for 60 per cent of global vaccine production making it the largest vaccine producer in the world. India is also one of the biggest suppliers of low-cost vaccines in the world and is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume.

“Further, India has supplied over 298 million COVID-19 vaccines to around 100 countries across the globe under Vaccine Maitri initiative (till May 19, 2023),” said the Ministry. It added that an investment of Rs 21,861 crore was received under PLI Schemes till June.

Related Posts

  • Pharma
  • December 23, 2024
  • 48 views
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

  • Pharma
  • December 23, 2024
  • 72 views
NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt